SEC Tracker
Get the app

Rapport Therapeutics RAPP

Rapport Therapeutics: Securities offering

Securities offering

Form
FWP
Filed
Importance
Routine
  1. Pricing of $175M common stock offering at $21.00 per share
  2. Pricing of $150M convertible notes due 2032 at 2.25% interest
  3. Concurrent private placement of $30M common stock with one investor

Written from the FWP on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Rapport Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Abeona Therapeutics ABEO public float $273M, Jun 30, 2025
  2. Ocugen OCGN public float $279M, Jun 30, 2025
  3. Tonix Pharmaceuticals Holding TNXP public float $271M, Jun 30, 2025
  4. Vanda Pharmaceuticals VNDA public float $269M, Jun 30, 2025
  5. Atea Pharmaceuticals AVIR public float $263M, Jun 30, 2025